MedTrace Logo

Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding

NCT03980496 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-06-10

No results posted yet for this study

Summary

The aim of the study is to identify the best method of omeprazole (OME) application with respect to intragastric pH, cytochrome P450 2C19 (CYP2C19) genotype and phenotype.

Conditions

  • Non-variceal Upper Gastrointestinal Bleeding

Interventions

DRUG

Omeprazole

Sponsors & Collaborators

  • National Science Centre, Poland

    collaborator OTHER_GOV

  • Medical University of Bialystok

    lead OTHER

Principal Investigators

  • Andrzej Dabrowski, Prof. · Medical University of Bialystok

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-09
Primary Completion
2013-06-08
Completion
2013-06-08

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03980496 on ClinicalTrials.gov